Fennec Pharmaceuticals Ord Shs T.FRX

Alternate Symbol(s): FENC

Healthcare Biotechnology

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase 3 clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6. It has established Fennec HEARS, a single source program designed to connect PEDMARK patients.

TSX:FRX - Post by User

Fennec Pharmaceuticals Ord Shs

Bullboard Posts

Comment by dollarhunteron Aug 01, 2007 1:28pm

211 Views

Post# 13186493

RE: Hello? Anyone around?

I'm still here yakky. Been here for years now slowly accumulating as I feel there is great potential for AHX as well as my investment. Sit back and relax while the brokers are on vacation. With any luck as they all head back to their blackberries and desks come September AHX will have somthing to report that will send the share price north. Expect low volume until then with the price hovering around where it currently is. As for me I probably won't take the chance of flipping for a gain of a few shares now as I feel the next release could be the one to blast the share price up. Regards, DH

Bullboard Posts

How one company is disrupting PoC testing